| Literature DB >> 35286471 |
Nafi'u Haladu1,2, Adegoke Alabi1,3, Miriam Brazzelli4, Mari Imamura4, Irfan Ahmed5, George Ramsay4,5, Neil W Scott6.
Abstract
BACKGROUND: Inguinal hernia has a lifetime incidence of 27% in men and 3% in women. Surgery is the recommended treatment, but there is no consensus on the best method. Open repair is most popular, but there are concerns about the risk of chronic groin pain. Laparoscopic repair is increasingly accepted due to the lower risk of chronic pain, although its recurrence rate is still unclear. The aim of this overview is to compare the risk of recurrence and chronic groin pain in laparoscopic versus open repair for inguinal hernia.Entities:
Keywords: Inguinal hernia surgery; Laparoscopic repair; Open repair; Overview of systematic reviews; Primary hernia; Recurrent hernia
Mesh:
Year: 2022 PMID: 35286471 PMCID: PMC9160137 DOI: 10.1007/s00464-022-09161-6
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 3.453
Fig. 1PRISMA flow diagram
Characteristics of included reviews
| Review ID | Search dates | No. of studies analysed | No. of participants | Gender | Age in years | Hernia types | Comparison | |
|---|---|---|---|---|---|---|---|---|
| Primary or Recurrent | Unilateral or Bilateral | |||||||
| Lyu [ | Up to Sept. 2018 | 31 | 5594 | All | 25–69 | PH, RH | UH, BH | TEP vs Lichtenstein, TAPP vs Lichtenstein |
| Aiolfi 2019 [ | 2000 to Feb. 2019 | 12 | 3748 | All | 18–76 | PH | UH | TEP vs Open, TAPP vs Open |
| Bullen 2019 [ | Up to April 2019 | 12 | 3966 | All | NR (≥ 16) | PH | UH | Lap vs Lichtenstein |
| Gavrilidis 2019 [ | 1989 to 2019 | 21 | 6573 | NR | 36–68 | NR | NR | TEP vs Lichtenstein |
| Patterson 2019 [ | Jan 1998 to May 2018 | 58 | 17,510 | All | 23.6—65.4 | NR | NR | Lap vs Open, TAPP vs Lichtenstein, TAPP vs Shouldice, TEP vs Lichtenstein, TEP vs Shouldice |
| Scheuermann 2017 [ | Up to July 2016 | 8 | 896 | All | 19–84 | PH | NR | TAPP vs Lichtenstein |
| Pisanu 2015 [ | 1966 to 2013 | 7 | 688 | All | 42–75 | RH | NR | Lap vs Lichtenstein |
| Li 2014 [ | Jan 1999 to Sept 2012 | 6 (11) | 643 (1311) | NR | NR | RH | NR | Lap vs Open |
| Zheng 2014 [ | Up to Jan 2013 | 13 | 3279 | All | NR (18–100) | PH, RH | NR | TEP vs Lichtenstein |
| Koning 2013 [ | 1966 to Jan 2012 | 13 | 5404 | All | NR (Adults) | PH | UH, BH | TEP vs Lichtenstein |
| Yang 2013 [ | 1966 to May 2012 | 5 | 429 | NR | 52–66 | RH | NR | Lap vs Lichtenstein |
| O’Reily 2012 [ | Up to March 2012 | 27 | 7161 | NR | 35.6—65.5 | PH | UH | Lap vs Open, TEP vs Open, TAPP vs Open |
| Aly 2011 [ | 1995 to May 2010 | 8 | 5300 | NR | 16–85 | NR | NR | Lap vs Open |
| Dedemadi 2010 [ | 1990 to 2008 | 7 | 663 | All | 55.8–64 | RH | NR | TEP vs Lichtenstein, Lap vs Lichtenstein |
| Karthikesalingam 2010 [ | 1966 to 2009 | 4 | 404 | NR | NR | RH | NR | Lap vs Open |
| Kuhry 2007 [ | NR | 23 | 4231 | NR | NR | NR | NR | TEP vs Open |
| Schmedt 2005 [ | Up to April 2014 | 34 | 7223 | NR | NR | NR | NR | Lap vs Lichtenstein |
| McCormack 2003 [ | NR | 41 | 7161 | All | NR (= / > 18) | PH, RH | UH, BH | Lap vs Open, TEP vs Open, TAPP vs Open |
| Memon 2003 [ | Jan 1990 to Oct 2000 | 29 | 5588 | NR | NR | NR | NR | Lap vs Open, TEP vs Open, TAPP vs Open |
| Schmedt 2002 [ | NR | 33 | 5053 | NR | NR | NR | NR | Lap vs Lichtenstein, Lap vs Shouldice |
| Chung 1999 [ | May 1994 to March 1997 | 14 | 2471 | NR | NR | NR | NR | Lap vs Shouldice, TAPP vs Lichtenstein |
NR not reported, PH Primary inguinal hernia, RH Recurrent inguinal hernia, UH Unilateral hernia, BH Bilateral hernia, TAPP Transabdominal pre-peritoneal repair, TEP Totally extra-peritoneal repair, Lap Laparoscopic procedure, * Age range normally reported but where not available, the age policy for review noted in brackets, + Mixed method studies with No. of RCTs/participants displayed and total no. of studies/participants in brackets
Summary of risk of bias for included reviews (AMSTAR 2 Checklist)
| Review ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Overall confidence rating |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lyu 202014 | Y | PY | N | PY | Y | Y | PY | PY | Y | N | Y | N | Y | Y | N | Y | Moderate |
| Aiolfi 201915 | Y | Y | Y | PY | Y | Y | PY | Y | Y | N | Y | Y | Y | Y | N | Y | High |
| Bullen 201916 | Y | Y | N | Y | Y | Y | PY | Y | Y | N | Y | Y | Y | Y | Y | Y | High |
| Gavrilidis 201917 | Y | Y | N | Y | Y | Y | PY | Y | Y | N | Y | Y | Y | Y | N | Y | Moderate |
| Patterson 201918 | Y | PY | N | Y | Y | Y | PY | PY | Y | N | Y | Y | Y | Y | N | Y | Moderate |
| Scheuermann 201719 | Y | Y | Y | Y | N | N | PY | Y | Y | N | Y | Y | N | Y | Y | Y | Moderate |
| Pisanu 201520 | Y | Y | N | Y | Y | Y | PY | PY | Y | N | Y | Y | Y | Y | N | Y | Moderate |
| Li 2014 21 | Y | N | N | PY | Y | Y | PY | Y | Y | N | Y | Y | N | Y | Y | Y | Moderate |
| Zheng 201422 | Y | N | N | PY | N | Y | PY | Y | Y | N | Y | Y | N | Y | N | Y | Low |
| Koning 201323 | Y | Y | N | PY | Y | Y | PY | Y | Y | N | Y | Y | Y | Y | N | Y | Moderate |
| Yang 201324 | Y | N | N | Y | Y | Y | PY | Y | Y | N | Y | N | N | Y | N | Y | Low |
| O’Reily 201225 | Y | N | N | PY | N | N | PY | Y | Y | N | Y | Y | Y | Y | N | Y | Low |
| Aly 201126 | Y | N | N | Y | N | N | N | Y | Y | N | Y | Y | Y | Y | N | N | Low |
| Dedemadi 201027 | Y | N | N | Y | Y | Y | N | Y | Y | N | Y | Y | Y | Y | Y | N | Low |
| Karthikesalingam 201028 | Y | N | N | Y | Y | Y | PY | Y | Y | N | Y | Y | Y | Y | Y | Y | Moderate |
| Kuhry 200729 | Y | N | N | PY | N | N | N | PY | N | N | NA | NA | N | Y | NA | N | Critically low |
| Schmedt 200530 | Y | N | N | N | N | N | Y | Y | PY | N | Y | Y | N | Y | N | N | Low |
| McCormack 200310 | Y | Y | N | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | N | Y | Moderate |
| Memon 20038 | Y | N | N | PY | Y | Y | N | PY | Y | N | Y | Y | Y | Y | N | N | Low |
| Schmedt 200231 | Y | N | N | N | N | N | N | Y | N | N | NA | NA | N | Y | NA | N | Critically low |
| Chung 199932 | Y | N | N | N | N | N | N | Y | N | N | Y | N | N | N | N | N | Critically low |
1-Participants, interventions, comparators, outcomes (PICO) components; 2- Predetermined protocol; 3-Explanation for study design choice; 4-Comprehensive literature search; 5-Duplicate study selection; 6-Duplicate data extraction; 7-List of excluded studies; 8-Description of included studies; 9-Satisfactory risk of bias (ROB) assessment for included studies in the review; 10- Funding sources for included studies in the review; 11- Appropriate method for meta-analysis; 12-Impact of study ROB on results; 13- Impact of ROB in interpretation of results; 14- Explanation for heterogeneity in results; 15- Publication bias; 16- Conflicts of interest; Y- Yes; N- No; PY- Partial yes; NA- not applicable
Results for Hernia recurrence (OR/RR > 1 or RD > 0 favours Open/Open mesh/Open non-mesh repairs)
| Review ID | Type(s) of Hernia | Effect measure | Primary or mixed hernia | Recurrent hernia | Study quality (AMS-TAR2)* | Comments | |||
|---|---|---|---|---|---|---|---|---|---|
| Recurrence rates | No. of studies | Effect size (95% CI/CrI) | No. of studies | Effect size | |||||
| Patterson 2019 [ | All | RR | Lap (4.4%) Open (3.9%) | 46 (15,605) | 0.94 (0⋅72, 1.24) | M | Included only studies published after Jan 1998 | ||
| McCormack 2003 [ | All | Peto OR | Lap 86/3138 (2.7%) Open 109/3504 (3.1%) | 27 (6642) | 0.81 (0.61, 1.08) | 11 (387) | 1.04 (0.45, 2.43) | M | |
| O’Reilly 2012 [ | PH, UH | RR | NR | 18 (6874) | 2.06 (1.26, 3.37) | L | |||
| Li 2014 [ | RH | RD | 6 (643) | − 0.01 (− 0.06, 0.03) | M | ||||
| Kerthakesalingam 2010 [ | RH | OR | 4 (NR) | 0·84 (0·33, 2·17) | M | ||||
| Aly 2011 [ | NR | OR | Lap 125/2047 (6.1%) Open 59/2079 (2.8%) | 6 (4126) | 2.17 (1.58, 2.98) | L | |||
| Memon 2003 [ | NR | OR | Lap 89/2864 (3.1%) Open 81/2818 (2.9%) | 20 (5682) | 1·51 (0·81, 2·79) | L | |||
| Bullen 2019 [ | PH, UH | OR | Lap 55/1865 (2.9%) Open 45/1758 (2.6%) | 9 (3623) | 1.14 (0.51, 2.55) | H | Included studies with follow-up duration up to 12 months | ||
| Pisanu 2015 [ | RH | OR | 5 (534) | 0.67 (0.39, 1.16) | M | ||||
| Yang 2013 [ | RH | OR | 5 (427) | 0.68 (0.33, 1.41) | L | ||||
| Dedemadi 2010 [ | RH | RR | 7 (706) | 0.72 (0.45, 1.14) | L | ||||
| Schmedt 2005 [ | NR | Peto OR | Lap 112/2042 (5.5%) Open 56/2058 (2.7%) | 14 (4100) | 2.00 (1.46, 2.74) | L | Excluded studies that considered IPOM as endoscopic procedure | ||
| Schmedt 2002 [ | NR | NR | 11 (3482) | NR | CL | No significant difference reported | |||
| Schmedt 2002 [ | NR | NR | 18 (2700) | NR | CL | No significant difference reported | |||
| Chung 1999 [ | NR | OR | NR | 6 (1711) | -1.48 (-4.31, 1.34) | CL | Negative values for odds ratios were reported and it’s unclear what this effect size represents | ||
| McCormack 2003 [ | All | Peto OR | Lap 50/1763 (2.8%) Open 71/2126 (3.3%) | 27 (3889) | 0.76 (0.52, 1.09) | 10 (276) | 0.99 (0.39, 2.51) | M | IPD |
| Aiolfi 2019 [ | PH, UH | RR | NR | NR | 0.96 (0.57, 1.51) | H | NMA | ||
| O’Reilly 2012 [ | PH, UH | RR | NR | 11 (2656) | 1.14 (0.78, 1.68) | L | |||
| Memon 2003 [ | NR | OR | Lap 54/1985 (2.7%) Open 41/1904 (2.2%) | 15 (3862) | 1·52 (0·68, 3·41) | L | |||
| Lyu 2020 [ | All | OR | NR | NR | 1.7 (0.56, 5.5) | M | NMA | ||
| Patterson 2019 [ | All | RR | NR | 12 (NR) | 0⋅79 (0⋅52, 1⋅21) | NR | M | ||
| McCormack 2003 [ | All | Peto OR | Lap 22/912 (2.4%) Open 21/918 (2.3%) | 12 (1830) | 1.01 (0.56, 1.85) | 5 (190) | 1.20 (0.43, 3.32) | IPD | |
| Scheuermann 2017 [ | PH | OR | Lap 9/337 (2.7%) Open 6/322 (1.9%) | 6 (659) | 1.17 (0.39, 3.57) | M | Excluded irreducible and incarcerated hernia requiring emergency surgery | ||
| Chung 1999 [ | NR | OR | NR | 6 (607) | 0.00 (-0.16, 0.16) | CL | |||
| Patterson 2019 [ | All | RR | NR | 8 (NR) | 0⋅96 (0⋅69, 1⋅33) | M | Included only studies published after Jan 1998 | ||
| McCormack 2003 [ | All | Peto OR | Lap 26/1140 (2.3%) Open 47/1119 (4.2%) | 16 (2259) | 0.45 (0.28, 0.72) | 4 (93) | 0.31 (0.04, 2.26) | M | IPD |
| McCormack 2003 [ | All | Peto OR | Lap 34/1375 (2.5%) Open 38/1378 (2.8%) | 7 (2753) | 0.91 (0.57, 1.46) | 2 (111) | 1.33 (0.18, 10.06) | M | IPD |
| Aiolfi 2019 [ | PH, UH | RR | NR | NR | 1.0 (0.65, 1.61) | H | NMA | ||
| O’Reilly 2012 [ | PH, UH | RR | NR | 10 (3063) | 3.72 (1.66, 8.35) | L | |||
| Kuhry 2007 [ | NR | NR | 15 (2937) | NR | CL | 1 of 15 studies showed statistically significant lower recurrence in TEP, others reported no difference | |||
| Memon 2003 [ | NR | OR | Lap 25/856 (2.9%) Open 36/887 (4.1%) | 4 (1743) | 0·98 (0·35, 2·70) | L | |||
| Lyu 2020 [ | All | OR | NR | NR | 0.85 (0.26, 2.0) | M | NMA | ||
| Patterson 2019 [ | All | RR | NR | 14 (NR) | 1⋅05 (0⋅58, 1⋅91) | M | Included only studies published after Jan 1998 | ||
| McCormack 2003 [ | All | Peto OR | Lap 7/351 (2.0%) Open 7/327 (2.1%) | 6 (678) | 0.97 (0.34, 2.77) | 1 (36) | 0.23 (0.01, 4.48) | IPD | |
| Zheng 2014 [ | All | RR | Lap 45/1645 (2.7%) Open 29/1742 (1.7%) | 9 (3387) | 1.64 (1.05, 2.55) | L | |||
| Koning 2013 [ | PH | RR | Lap 130/2582 (5.0%) Open 69/2598 (2.3%) | 12 (5180) | 1.89 (1.42, 2.50) | M | |||
| Dedemadi 2010 [ | RH | RR | 4 (344) | 0.48 (0.18, 1.33) | L | ||||
| Gavrilidis 2019 [ | NR | Peto OR | Lap 149/2678 (5.6%) Open 99/2790 (3.5%) | 14 (5468) | 1.58 (1.22, 2.04) | M | |||
| Patterson 2019 [ | All | OR | NR | 2 (NR) | 1⋅73 (0⋅07, 40⋅38) | NR | M | Included only studies published after Jan 1998 | |
| McCormack 2003[ | All | Peto OR | Lap 20/739 (2.7%) Open 31/780 (4.0%) | 5 (1519) | 0.67 (0.38, 1.18) | M | IPD | ||
*H high, M moderate, L low, CL critically low
# Review using qualitative synthesis and no meta-analysis
All includes both primary and recurrent inguinal hernias (PH and RH) and unilateral and bilateral inguinal hernias (UH and BH), BH Bilateral inguinal hernia, CI confidence interval, CrI credible interval, IPD used individual participant data, Lap laparoscopic, NMA network meta-analysis, NR not reported/no meta-analysis done, OR odds ratio, Peto OR Peto odds ratio, PH primary inguinal hernia, RCT randomised controlled trials, RD risk difference, RH recurrent inguinal hernia, RR relative risk, TAPP transabdominal pre-peritoneal repair, TEP totally extra-peritoneal repair, UH unilateral inguinal hernia
Results for Chronic pain (OR/RR > 1 or RD > 0 favours Open/Open mesh/Open non-mesh repairs)
| Review ID | Primary and mixed hernia | Recurrent hernia | Comments | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Type of Hernia | Review’s definition of chronic pain | Effect measure | Chronic pain rates | No. of studies (no. of participants) | Effect size (95% CI/CrI) | No. of studies (no. of participants) | Effect size (95% CI/CrI) | Study quality (AMS-TAR2)* | ||
| Patterson 2019 [ | All | Pain between 6 months and up to 1 year | RR | Lap 350/2999 (11.7%) Open 485/3133 (15.5%) | 17 (6132) | 0.74 (0⋅59, 0.93) | M | Included only studies published after Jan 1998 | ||
| All | Pain after 1 year | RR | Lap 314/4290 (7.3%) Open 537/4481 (12.0%) | 19 (8771) | 0.62 (0⋅47, 0⋅82) | M | ||||
| McCormack 2003 [ | All | Groin pain of any severity as near 12 months after the operation as possible provided this was at least after 3 months | Peto OR | Lap 290/2101 (13.8%) Open 459/2399 (19.1%) | 21 (749) | 0.54 (0.46, 0.64) | 8 (331) | 0.90 (0.50, 1.59) | M | IPD |
| O’Reilly 2012 [ | PH, UH | Persistence of symptoms beyond 1 month | RR | NR | 13 (4209) | 0.66 (0.51, 0.87) | L | |||
| Kerthakesalingam 2010 [ | RH | Severe chronic pain after at least 1 year | OR | 3 (NR) | 0·91 (0·14, 5·88) | M | ||||
| Bullen 2019 [ | PH | Pain lasting more than 6 months | OR | Lap 168/1780 (9.4%) Open 343/1665 (20.6%) | 10 (3445) | 0.41 (0.30, 0.56) | H | |||
| Pisanu 2015 [ | RH | NR | OR | 4 (377) | 0.39 (0.21, 0.72) | M | ||||
| Yang 2013 [ | RH | NR | Peto OR | 4 (377) | 0.33 (0.17, 0.68) | L | ||||
| Schmedt 2005 [ | NR | NR | Peto OR | Lap 125/1650 (7.6%) Open 208/1642 (12.7%) | 15 (3292) | 0.58 (0.44, 0.70) | L | |||
| Schmedt 2002 [ | NR | NR | NR | 8 (698) | NR | CL | 8 studies reported more pain in open mesh group | |||
| Schmedt 2002 [ | NR | NR | NR | 6 (990) | NR | CL | Most studies reported less pain in laparoscopic group | |||
| McCormack 2003 [ | All | Groin pain of any severity as near 12 months after the operation as possible provided this was at least after 3 months | Peto OR | Lap 150/1086 (13.8%) Open 227/1408 (16.1%) | 15 (2494) | 0·62 (0·49, 0·79) | 7 (209) | 1.00 (0.44, 2.25) | M | IPD |
| Aiolfi 2019 [ | PH, UH | NR | RR | NR | NR | 0.53 (0.27, 1.20) | H | NMA | ||
| O’Reilly 2012 [ | PH, UH | Persistence of symptoms beyond 1 month | RR | NR | 9 (2313) | 0.66 (0.50, 0.87) | L | |||
| McCormack 2003 [ | All | Groin pain of any severity as near 12 months after the operation as possible provided this was at least after 3 months | Peto OR | Lap 74/680 (10.9) Open 109/668 (16.3) | 7 (1348) | 0.59 [0.43, 0.83] | 3 (153) | 1.22 (0.49, 3.03) | M | IPD |
| Lyu 2020 [ | All | NR | OR | NR | NR | 0.51 (0.13, 1.7) | M | |||
| Scheuermann 2017 [ | PH | Persistent inguinal pain 3 months after surgery | OR | Lap 19/299 (6.4%) Open 37/284 (13.0%) | 5 (583) | 0.42 (0.23, 0.78) | M | Excluded irreducible and incarcerated hernia requiring emergency surgery | ||
| McCormack 2003 [ | All | Groin pain of any severity as near 12 months after the operation as possible provided this was at least after 3 months | Peto OR | Lap 48/618 (7.8%) Open 103/617 (16.7%) | 8 (1235) | 0.35 (0.24, 0.50) | 2 (53) | 0.18 (0.00, 9.42) | M | |
| McCormack 2003 [ | All | Groin pain of any severity as near 12 months after the operation as possible provided this was at least after 3 months | Peto OR | Lap 140/1015 (13.8%) Open 232/991 (23.4%) | 6 (2006) | 0·47 (0·36, 0·60) | 2 (122) | 0.80 (0.36, 1.81) | M | IPD |
| Aiolfi 2019 [ | PH, UH | NR | RR | NR | NR | 0.86 (0.48, 1.16) | H | NMA | ||
| O’Reilly 2012 [ | PH, UH | Persistence of symptoms beyond 1 month | RR | NR | 7 (2208) | 0.81 (0.45, 1.44) | H | |||
| McCormack 2003 [ | All | Groin pain of any severity as near 12 months after the operation as possible provided this was at least after 3 months | Peto OR | Lap 2/193 (1.0%) Open 17/157 (10.8%) | 3 (350) | 0.13 (0.05, 0.34) | 1 (36) | 0.19 (0.01, 3.32) | M | IPD |
| Lyu 2020 [ | All | NR | OR | NR | NR | 0.85 (0.26, 2.0) | M | |||
| Zheng 2014 [ | All | Persistent groin pain or any groin discomfort affecting daily activities | RR | Lap 155/1368 (11.3%) Open 233/1458 (16.05) | 9 (2826) | 0.70 (0.59, 0.85) | L | |||
| Koning 2013 [ | PH | Persisting pain for longer than 3 months | RR | Lap 334/2692 (12.4%) Open 454/2705 (16.8%) | 11 (5397) | 0.80 (0.61, 1.04) | M | |||
| Gavrilidis 2019 [ | NR | Pain of any severity (including testicular) persisting for more than 3 months after the operation | Peto OR | Lap 178/1617 (11.0%) Open 219/1680 (13.0%) | 13 (3479) | 0.81 (0.66, 1.00) | M | |||
| McCormack 2003 [ | All | Groin pain of any severity as near 12 months after the operation as possible provided this was at least after 3 months | Peto OR | Lap 13/498 (2.6%) Open 73/517 (14.1%) | 2 (1015) | 0.22 [0.14, 0.35] | M | IPD | ||
* H: high, M: moderate, L: low, CL: critically low
# Review using qualitative synthesis and no meta-analysis
All includes both primary and recurrent inguinal hernias (PH and RH) and unilateral and bilateral inguinal hernias (UH and BH), BH Bilateral inguinal hernia, CI confidence interval, CrI credible interval, IPD used individual participant data, Lap laparoscopic, NMA network meta-analysis, NR not reported/no meta-analysis done, OR odds ratio, Peto OR Peto odds ratio, PH primary inguinal hernia, RCT randomised controlled trials, RD risk difference, RH recurrent inguinal hernia, RR relative risk, TAPP transabdominal pre-peritoneal repair, TEP totally extra-peritoneal repair, UH unilateral inguinal hernia